Trial intelligence / Profile preview

Escitalopram vs Duloxetine in MDD

NCT01148472Phase 4Completed

Sponsor
Lundbeck
Start
Sep 2005
Primary completion
Sep 2006
Modality
Small Molecules
01

Overview

A Phase 4 trial of Escitalopram oxalate oral solution in major depressive disorder (MDD), sponsored by Lundbeck. Started Sep 2005; status: completed.

02

Drugs

Escitalopram oxalate oral solution
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT01148472.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01148472.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call